These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35901768)

  • 21. Impact of collateral flow on cost-effectiveness of endovascular thrombectomy.
    Khunte M; Wu X; Avery EW; Gandhi D; Payabvash S; Matouk C; Heit JJ; Wintermark M; Albers GW; Sanelli P; Malhotra A
    J Neurosurg; 2022 Dec; 137(6):1801-1810. PubMed ID: 35535841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expansion of the dimensions in the current management of acute ischemic stroke.
    Malik P; Anwar A; Patel R; Patel U
    J Neurol; 2021 Sep; 268(9):3185-3202. PubMed ID: 32436103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endovascular and thrombolytic treatment eligibility in childhood arterial ischemic stroke.
    Hutchinson ML; Beslow LA; Shih EK; Licht DJ; Kimmel AC; Granath C; Ichord RN
    Eur J Paediatr Neurol; 2021 Sep; 34():99-104. PubMed ID: 34454335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of recombinant tissue-type plasminogen activator within 3 hours of acute ischemic stroke: current evidence.
    Boudreau DM; Guzauskas GF; Chen E; Lalla D; Tayama D; Fagan SC; Veenstra DL
    Stroke; 2014 Oct; 45(10):3032-9. PubMed ID: 25190439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanical Thrombectomy Versus Best Medical Management for Acute Ischemic Stroke in Elderly Patients: A Cost-Effectiveness Analysis.
    Lim J; Monteiro A; Ruggiero N; Baig AA; Aguirre AO; McPheeters MJ; Waqas M; Vakharia K; Snyder KV; Siddiqui AH; Levy EI; Davies JM
    World Neurosurg; 2023 Jul; 175():e730-e737. PubMed ID: 37037370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of intra-arterial thrombolysis following successful endovascular thrombectomy on functional outcomes in patients with large vessel occlusion acute ischemic stroke: A post-CHOICE meta-analysis.
    Elfil M; Ghozy S; Elmashad A; Ghaith HS; Aladawi M; Dicpinigaitis AJ; Mansour OY; Khandelwal P; Asif K; Nour M; Toth G; Al-Mufti F
    J Stroke Cerebrovasc Dis; 2023 Aug; 32(8):107194. PubMed ID: 37216750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness analysis of mechanical thrombectomy with stent retriever in the treatment of acute ischemic stroke in Italy.
    Ruggeri M; Basile M; Zini A; Mangiafico S; Agostoni EC; Lobotesis K; Saver J; Coretti S; Drago C; Cicchetti A
    J Med Econ; 2018 Sep; 21(9):902-911. PubMed ID: 29882711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and Feasibility of Argatroban, Recombinant Tissue Plasminogen Activator, and Intra-Arterial Therapy in Stroke (ARTSS-IA Study).
    Berekashvili K; Soomro J; Shen L; Misra V; Chen PR; Blackburn S; Dannenbaum M; Grotta JC; Barreto AD
    J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3647-3651. PubMed ID: 30249518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endovascular thrombectomy with or without intravenous alteplase for acute ischemic stroke due to large vessel occlusion: a systematic review and meta-analysis of randomized trials.
    Wang X; Ye Z; Busse JW; Hill MD; Smith EE; Guyatt GH; Prasad K; Lindsay MP; Yang H; Zhang Y; Liu Y; Tang B; Wang X; Wang Y; Couban RJ; An Z
    Stroke Vasc Neurol; 2022 Dec; 7(6):510-517. PubMed ID: 35725244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endovascular treatment or general treatment: how should acute ischemic stroke patients choose to benefit from them the most?: A systematic review and meta-analysis.
    Yang W; Zhang L; Yao Q; Chen W; Yang W; Zhang S; He L; Li H; Zhang Y
    Medicine (Baltimore); 2020 May; 99(20):e20187. PubMed ID: 32443338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of Mechanical Thrombectomy More Than 6 Hours After Symptom Onset Among Patients With Acute Ischemic Stroke.
    Peultier AC; Pandya A; Sharma R; Severens JL; Redekop WK
    JAMA Netw Open; 2020 Aug; 3(8):e2012476. PubMed ID: 32840620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of endovascular treatment for acute ischemic stroke in China: evidence from Shandong Peninsula.
    Han L; Lan K; Kou D; Meng Z; Feng J; Maitland E; Nicholas S; Wang J
    Health Econ Rev; 2024 Jun; 14(1):37. PubMed ID: 38836982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous tPA (Tissue-Type Plasminogen Activator) Correlates With Favorable Venous Outflow Profiles in Acute Ischemic Stroke.
    Faizy TD; Mlynash M; Marks MP; Christensen S; Kabiri R; Kuraitis GM; Broocks G; Winkelmeier L; Geest V; Nawabi J; Lansberg MG; Albers GW; Fiehler J; Wintermark M; Heit JJ
    Stroke; 2022 Oct; 53(10):3145-3152. PubMed ID: 35735008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Costs and health effects of CT perfusion-based selection for endovascular thrombectomy within 6 hours of stroke onset: a model-based health economic evaluation.
    van Voorst H; Hoving JW; Koopman MS; Daems JD; Peerlings D; Buskens E; Lingsma H; Marquering HA; de Jong HWAM; Berkhemer OA; van Zwam WH; van Walderveen MAA; van den Wijngaard IR; Dippel DWJ; Yoo AJ; Campbell B; Kunz WG; Majoie CB; Emmer BJ; ; ;
    J Neurol Neurosurg Psychiatry; 2024 May; 95(6):515-527. PubMed ID: 38124162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of endovascular thrombectomy with and without bridging thrombolysis for acute large vessel occlusion ischaemic stroke.
    Maingard J; Shvarts Y; Motyer R; Thijs V; Brennan P; O'Hare A; Looby S; Thornton J; Hirsch JA; Barras CD; Chandra RV; Brooks M; Asadi H; Kok HK
    Intern Med J; 2019 Mar; 49(3):345-351. PubMed ID: 30091271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke in China.
    Pan Y; Chen Q; Zhao X; Liao X; Wang C; Du W; Liu G; Liu L; Wang C; Wang Y; Wang Y;
    PLoS One; 2014; 9(10):e110525. PubMed ID: 25329637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute Ischemic Stroke Interventions in the United States and Racial, Socioeconomic, and Geographic Disparities.
    de Havenon A; Sheth K; Johnston KC; Delic A; Stulberg E; Majersik J; Anadani M; Yaghi S; Tirschwell D; Ney J
    Neurology; 2021 Dec; 97(23):e2292-e2303. PubMed ID: 34649872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is Endovascular Therapy for Stroke Cost-Effective Globally? A Systematic Review of the Literature.
    Waqas M; Gong AD; Levy BR; Dossani RH; Vakharia K; Cappuzzo JM; Becker A; Sonig A; Tutino VM; Almayman F; Davies JM; Snyder KV; Siddiqui AH; Levy EI
    J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105557. PubMed ID: 33556672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute ischemic strokes in patients with developmental disabilities: A cross-sectional analysis.
    Lui A; Feldstein E; Clare K; Dicpinigaitis AJ; Reddy M; Khan F; Semaan R; Galluzzo D; Shapiro S; Kamal H; Yaghi S; Pisapia J; Muh C; Nuoman R; Overby P; Etienne M; Chong J; Mayer S; Gandhi CD; Al-Mufti F
    Interv Neuroradiol; 2023 Oct; 29(5):555-560. PubMed ID: 35786031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of mechanical thrombectomy within 6 hours of acute ischaemic stroke in China.
    Pan Y; Cai X; Huo X; Zhao X; Liu L; Wang Y; Miao Z; Wang Y
    BMJ Open; 2018 Feb; 8(2):e018951. PubMed ID: 29472264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.